patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Today's News, May 22, 2012 TD AMERITRADE

Today's News, May 22, 2012

6:51a
Needham Initiates Coverage on Pluristem Therapeutics at Buy, Announces PT of $5 (Benzinga)

No link available. Just a listed headline on TD Ameritrade.

Share
New Message
Please login to post a reply